Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Steinbach

Showing results (281-290 of 369) with videos related to

Pageof 37
Sort By:
Neuro-Oncology|June 4, 2024
Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasisJenny Roesler, Daniel Spitzer, Xiaoxiong Jia, et al.
International Journal of Molecular Sciences|May 9, 2017
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and LomustineDavid Capper, Andreas von Deimling, Alba A Brandes, et al.
Neuro-Oncology|February 18, 2020
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytomaAntje Wick, Tobias Kessler, Michael Platten, et al.
Journal of Neuro-Oncology|July 21, 2022
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysisAnna-Luisa Luger, Sven König, Patrick Felix Samp, et al.
Cell Reports. Medicine|March 7, 2026
Integrative CSF profiling identifies disease-specific immune responses in leptomeningeal diseasePaula Nieto, Svenja Klinsing, Ginevra Caratù, et al.
Neuro-Oncology|April 19, 2013
Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collectiveBenedikt Wiestler, Rainer Claus, Sabine A Hartlieb, et al.
Brain Pathology (Zurich, Switzerland)|December 4, 2018
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomasPia S Zeiner, Corinna Preusse, Anna Golebiewska, et al.
International Journal of Cancer|March 12, 2014
Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profilingGuido Reifenberger, Ruthild G Weber, Vera Riehmer, et al.
Journal of Cancer Research and Clinical Oncology|May 30, 2018
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trialChristina Schaub, Sied Kebir, Nina Junold, et al.
The Journal of Clinical Investigation|February 5, 2020
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumorsMichael W Ronellenfitsch, Patrick N Harter, Martina Kirchner, et al.
Pageof 37

Showing results (281-290 of 369) with videos related to

Sort By:
Pageof 37
Neuro-Oncology|June 4, 2024
Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasisJenny Roesler, Daniel Spitzer, Xiaoxiong Jia, et al.
International Journal of Molecular Sciences|May 9, 2017
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and LomustineDavid Capper, Andreas von Deimling, Alba A Brandes, et al.
Neuro-Oncology|February 18, 2020
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytomaAntje Wick, Tobias Kessler, Michael Platten, et al.
Journal of Neuro-Oncology|July 21, 2022
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysisAnna-Luisa Luger, Sven König, Patrick Felix Samp, et al.
Cell Reports. Medicine|March 7, 2026
Integrative CSF profiling identifies disease-specific immune responses in leptomeningeal diseasePaula Nieto, Svenja Klinsing, Ginevra Caratù, et al.
Neuro-Oncology|April 19, 2013
Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collectiveBenedikt Wiestler, Rainer Claus, Sabine A Hartlieb, et al.
Brain Pathology (Zurich, Switzerland)|December 4, 2018
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomasPia S Zeiner, Corinna Preusse, Anna Golebiewska, et al.
International Journal of Cancer|March 12, 2014
Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profilingGuido Reifenberger, Ruthild G Weber, Vera Riehmer, et al.
Journal of Cancer Research and Clinical Oncology|May 30, 2018
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trialChristina Schaub, Sied Kebir, Nina Junold, et al.
The Journal of Clinical Investigation|February 5, 2020
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumorsMichael W Ronellenfitsch, Patrick N Harter, Martina Kirchner, et al.
Pageof 37